Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

APO-SIBUTRAMINE DIN 02337614

Status: Cancelled Post Market
Holder: APOTEX INC
Molecule: SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE

Health Canada record

Active ingredient(s)SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE 10 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCA08AA10 SIBUTRAMINE
Original market date23-Nov-2009
Current status date12-Oct-2010
SourceHealth Canada DPD

Establishment licence of the holder

Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE

DINProductCompanyFormStrengthStatus
02337622APO-SIBUTRAMINEAPOTEX INCCapsuleSIBUTRAMINE HYDROCHLORIDE MONOHYDRATE 15 MGCancelled Post Market
02243163MERIDIAABBOTT LABORATORIES, LIMITEDCapsuleSIBUTRAMINE HYDROCHLORIDE MONOHYDRATE 10 MGCancelled Post Market
02243164MERIDIAABBOTT LABORATORIES, LIMITEDCapsuleSIBUTRAMINE HYDROCHLORIDE MONOHYDRATE 15 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
107922009-11-23Abbreviated New Drug Submission (ANDS)

International API supply for SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE

0 active FDA Drug Master Files.

Request a quote for APO-SIBUTRAMINE

How to read a Canadian DIN record